SPY389.57+9.21 2.42%
DIA316.11+6.66 2.15%
IXIC13,537.68+345.33 2.62%

BRIEF-Stoke Therapeutics Inc - In January 2021 It Initiated Enrollment And Dosing In Company's Swallowtail Open Label Extension Study For Stk-001

· 02/05/2021 16:30
BRIEF-Stoke Therapeutics Inc - In January 2021 It Initiated Enrollment And Dosing In Company's Swallowtail Open Label Extension Study For Stk-001

- Stoke Therapeutics Inc STOK.O:

  • STOKE THERAPEUTICS INC - IN JANUARY 2021 IT INITIATED ENROLLMENT AND DOSING IN COMPANY'S SWALLOWTAIL OPEN LABEL EXTENSION STUDY FOR STK-001

Source text for Eikon: [https://bit.ly/3oTYbEm]

Further company coverage: STOK.O


((Reuters.Briefs@thomsonreuters.com;))